Etienne Garin Selected Research

Ethiodized Oil (Ethiodol)

7/2019	Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.
3/2012	Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity.
2/2012	Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
1/2012	(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.
9/2011	Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach.
6/2011	¹³¹I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases.
10/2010	Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen.
9/2008	Dosimetric evaluation and therapeutic response to internal radiation therapy of hepatocarcinomas using iodine-131-labelled lipiodol.
3/2008	Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
1/2007	Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Etienne Garin Research Topics

Disease

37	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2004
23	Neoplasms (Cancer) 01/2022 - 03/2008
8	Cholangiocarcinoma 01/2022 - 11/2015
6	Thrombosis (Thrombus) 05/2019 - 01/2010
5	Neoplasm Metastasis (Metastasis) 12/2021 - 03/2010
5	Liver Neoplasms (Liver Cancer) 05/2016 - 02/2012
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 02/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2019 - 11/2015
2	Hypertrophy 01/2018 - 08/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2011 - 06/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2011 - 12/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Ascites 01/2021
1	Jaundice (Icterus) 01/2021
1	Liver Failure 01/2021
1	Rectal Diseases (Rectal Disease) 09/2020
1	Rheumatoid Arthritis 01/2019
1	Ischemic Stroke 02/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Neutropenia 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Fibrosis (Cirrhosis) 03/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2014
1	Hepatoblastoma 09/2013
1	Ulcer 05/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2011
1	Respiratory Insufficiency (Respiratory Failure) 06/2011
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2010
1	Parkinson Disease (Parkinson's Disease) 08/2010
1	Disease Progression 06/2009
1	Breast Neoplasms (Breast Cancer) 12/2006
1	Residual Neoplasm 12/2006
1	Experimental Liver Neoplasms 10/2004

Drug/Important Bio-Agent (IBA)

11	SirtuinsIBA 01/2022 - 11/2015
11	Ethiodized Oil (Ethiodol)FDA Link 07/2019 - 10/2004
9	Yttrium-90IBA 01/2022 - 03/2015
7	AlbuminsIBA 01/2021 - 12/2011
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2020 - 12/2006
6	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 09/2013
4	fluoromethylcholineIBA 01/2019 - 02/2017
2	YttriumIBA 01/2022 - 01/2020
2	Radioisotopes (Radionuclides)IBA 01/2019 - 01/2010
2	RadiopharmaceuticalsIBA 01/2019 - 03/2011
2	Choline (Choline Chloride)IBA 05/2018 - 02/2017
2	Rhenium-188IBA 01/2012 - 03/2011
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 01/2020
1	Technetium (Technetium 99m)IBA 01/2020
1	macro aggregates of albuminIBA 01/2018
1	mahuang-tangIBA 01/2018
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017
1	Coloring Agents (Dyes)IBA 12/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2015
1	Gemcitabine FDA Link 12/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2015
1	RheniumIBA 09/2013
1	stearic acid (magnesium stearate)FDA LinkGeneric 03/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2011
1	Pharmaceutical PreparationsIBA 06/2011
1	LipidsIBA 03/2011
1	NanocapsulesIBA 03/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010
1	Rituximab (Mabthera)FDA Link 12/2010
1	Prednisone (Sone)FDA LinkGeneric 12/2010
1	Vincristine (Oncovin)FDA LinkGeneric 12/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2010
1	Tamoxifen FDA LinkGeneric 10/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2010
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2009
1	Iodine-131IBA 09/2008
1	Therapeutic UsesIBA 01/2007
1	Cisplatin (Platino)FDA LinkGeneric 03/2006
1	LUFIBA 06/2005
1	EmulsionsIBA 06/2005
1	Iodized OilIBA 06/2005

Therapy/Procedure

27	Microspheres (Microsphere) 01/2022 - 01/2010
18	Radiotherapy 01/2022 - 10/2004
10	Therapeutics 01/2022 - 01/2007
8	Drug Therapy (Chemotherapy) 12/2021 - 12/2006
4	Intra-Arterial Injections 01/2010 - 03/2006
2	Radioimmunotherapy 01/2017 - 02/2013
2	Deep Brain Stimulation 12/2010 - 08/2010
1	Contraindications 01/2021
1	Immunotherapy 08/2020
1	Induction Chemotherapy 01/2017
1	Transplantation 01/2017
1	Palliative Care (Palliative Therapy) 09/2013
1	Aftercare (After-Treatment) 10/2010
1	Neoadjuvant Therapy 12/2006